These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 24491153)
1. Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study. Matuschek C; Lehnhardt M; Gerber PA; Poremba C; Hamilton J; Lammering G; Orth K; Budach W; Bojar H; Bölke E; Peiper M Eur J Med Res; 2014 Feb; 19(1):6. PubMed ID: 24491153 [TBL] [Abstract][Full Text] [Related]
2. CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Li Z; Chen K; Jiang P; Zhang X; Li X; Li Z Diagn Pathol; 2014 Apr; 9():79. PubMed ID: 24708709 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Impact of CD44 Expression in Patients With Myxofibrosarcoma. Tsuchie H; Emori M; Miyakoshi N; Nagasawa H; Okada K; Nanjyo H; Murahashi Y; Mizushima E; Shimizu J; Yamashita T; Shimada Y In Vivo; 2019; 33(6):2095-2102. PubMed ID: 31662543 [TBL] [Abstract][Full Text] [Related]
4. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival. Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890 [TBL] [Abstract][Full Text] [Related]
6. CD44v6 expression in primary breast carcinoma in western India: a pilot clinicopathologic study. Shah NG; Trivedi TI; Vora HH; Patel KC; Tankshali R; Goswami JV; Shukla SN; Shah PM Tumori; 2010; 96(6):971-7. PubMed ID: 21388061 [TBL] [Abstract][Full Text] [Related]
7. CD44 loss in gastric stromal tumors as a prognostic marker. Montgomery E; Abraham SC; Fisher C; Deasel MR; Amr SS; Sheikh SS; House M; Lilliemoe K; Choti M; Brock M; Ephron DT; Zahuruk M; Chadburn A Am J Surg Pathol; 2004 Feb; 28(2):168-77. PubMed ID: 15043305 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors and Outcomes for Patients With Myxofibrosarcoma: A 13-Year Retrospective Evaluation. Mühlhofer HML; Lenze U; Gersing A; Lallinger V; Burgkart R; Obermeier A; VON Eisenhart-Rothe R; Knebel C Anticancer Res; 2019 Jun; 39(6):2985-2992. PubMed ID: 31177139 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CD44 variants expression in colorectal cancer. Li XD; Ji M; Wu J; Jiang JT; Wu CP Tumori; 2013; 99(1):88-92. PubMed ID: 23549006 [TBL] [Abstract][Full Text] [Related]
11. CD44 expression in soft tissue sarcomas. Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753 [TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours. Imam H; Eriksson B; Oberg K Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495 [TBL] [Abstract][Full Text] [Related]
14. Correlation of CD44S expression in renal clear cell carcinomas with subsequent tumor progression or recurrence. Gilcrease MZ; Guzman-Paz M; Niehans G; Cherwitz D; McCarthy JB; Albores-Saavedra J Cancer; 1999 Dec; 86(11):2320-6. PubMed ID: 10590373 [TBL] [Abstract][Full Text] [Related]
15. Low serum levels of soluble CD44 variant 6 are significantly associated with poor prognosis in patients with pancreatic carcinoma. Gansauge F; Gansauge S; Rau B; Scheiblich A; Poch B; Schoenberg MH; Beger HG Cancer; 1997 Nov; 80(9):1733-9. PubMed ID: 9351541 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis. Jiang H; Zhao W; Shao W Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707 [TBL] [Abstract][Full Text] [Related]
17. Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival. Endo K; Terada T J Hepatol; 2000 Jan; 32(1):78-84. PubMed ID: 10673070 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study. Ma W; Deng Y; Zhou L Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):258-63. PubMed ID: 15997921 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal centre B cell-like types: a tissue microarray analysis of 90 cases. Tzankov A; Pehrs AC; Zimpfer A; Ascani S; Lugli A; Pileri S; Dirnhofer S J Clin Pathol; 2003 Oct; 56(10):747-52. PubMed ID: 14514777 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of CD44s expression in biliary tract cancers. Lee SM; Lee KE; Chang HJ; Choi MY; Cho MS; Min SK; Lee HK; Mun YC; Nam EM; Seong CM; Lee SN Ann Surg Oncol; 2008 Apr; 15(4):1155-60. PubMed ID: 18214619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]